Effects of antidepressant medication on emotion regulation in depressed patients: An iSPOT-D report

Journal of Affective Disorders

Volumn 159, Issue , 2014, Pages 127-132

  McRae, Kateri ^a   Rekshan, William ^b,e   Williams, Leanne M ^b,c,d,e   Cooper, Nicholas ^b,e   Gross, James J ^d  

^a UNIVERSITY OF DENVER   (United States)

^b Brain Resource Ltd   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d STANFORD UNIVERSITY   (United States)

^e Brain Resource International Database   (United States)

Author keywords

Anti depressant medication; Cognitive reappraisal; Emotion regulation; Expressive suppression; Major depressive disorder

Indexed keywords

ESCITALOPRAM; SERTRALINE; VENLAFAXINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CYCLOHEXANOL DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DISEASE ASSOCIATION; DRUG EFFECT; EMOTIONALITY; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; MIDDLE AGED; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; YOUNG ADULT; ADOLESCENT; CONTROLLED STUDY; DEFENSE MECHANISM; DEPRESSIVE DISORDER; DRUG EFFECTS; EMOTION; PSYCHOLOGY;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; CITALOPRAM; CYCLOHEXANOLS; DEPRESSIVE DISORDER; EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRESSION, PSYCHOLOGY; SERTRALINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896510697     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.12.037     Document Type: Article

References (35)

1. A. Aldao, S. Nolen-Hoeksema, and S. Schweizer Emotion-regulation strategies across psychopathology: a meta-analytic review Clin. Psychol. Rev. 30 2 2010 217 237 10.1016/j.cpr.2009.11.004
2. A. Anand, Y. Li, Y. Wang, K. Gardner, and M.J. Lowe Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an fMRI study J. Neuropsychiatry Clin. Neurosci. 19 3 2007 274 282 (Pubitemid 47293900)
3. A. Anand, Y. Li, Y. Wang, J. Wu, S. Gao, L. Bukhari, and M.J. Lowe Antidepressant effect on connectivity of the mood-regulating circuit: an fMRI study Neuropsychopharmacology 30 7 2005 1334 1344 10.1038/sj.npp.1300725 (Pubitemid 40848087)
4. R.M. Bagby, R.D. Levitan, S.H. Kennedy, A.J. Levitt, and R.T. Joffe Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: evidence of non-specificity Psychiatry Res. 86 3 1999 211 216 (Pubitemid 29393043)
5. L. Campbell-Sills, and D.H. Barlow Incorporating emotion regulation into conceptualizations and treatments of anxiety and mood disorders J.J. Gross, Handbook of Emotion Regulation 2007 Guilford New York 542 559
6. C.-H. Chen, K. Ridler, J. Suckling, S. Williams, C.H.Y. Fu, E. Merlo-Pich, and E. Bullmore Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment Biol. Psychiatry 62 5 2007 407 414 10.1016/j.biopsych.2006.09.018 (Pubitemid 47284016)
7. A. Chiesa, P. Brambilla, and A. Serretti Functional neural correlates of mindfulness meditations in comparison with psychotherapy, pharmacotherapy and placebo effect. Is there a link? Acta Neuropsychiatr. 22 3 2010 104 117 10.1111/j.1601-5215.2010.00460.x
8. R.J. DeRubeis, S.D. Hollon, J.D. Amsterdam, R.C. Shelton, P.R. Young, R.M. Salomon, and R. Gallop Cognitive therapy vs medications in the treatment of moderate to severe depression Arch. Gen. Psychiatry 62 4 2005 409 416 10.1001/archpsyc.62.4.409 (Pubitemid 40471690)
9. R.J. DeRubeis, G.J. Siegle, and S.D. Hollon Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. [10.1038/nrn2345] Nat. Rev. Neurosci. 9 10 2008 788 796 10.1038/nrn2345
10. W.C. Drevets Prefrontal cortical-amygdalar metabolism in major depression Ann. N. Y. Acad. Sci. 877 1 1999 614 637 10.1111/j.1749-6632.1999.tb09292.x (Pubitemid 29351882)
11. R. Entsuah, G.V. Upton, and R. Rudolph Efficacy of venlafaxine treatment in depressed patients with psychomotor retardation or agitation: a metaanalysis Hum. Psychopharmacol.: Clin. Exp. 10 3 1995 195 200 10.1002/hup.470100305
12. G.A. Fava, C. Rafanelli, S. Grandi, S. Conti, and P. Belluardo Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings Arch. Gen. Psychiatry 55 9 1998 816 820 10.1001/archpsyc.55.9.816 (Pubitemid 28413044)
13. K.L. Gratz, and L. Roemer Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale J. Psychopathol. Behav. Assess. 26 2004 41 54 10.1007/s10862-008-9102-4 (Pubitemid 38182213)
14. J.J. Gross The emerging field of emotion regulation: an integrative review Rev. Gen. Psychol. 2 1998 271 299 10.1037//1089-2680.2.3.271 (Pubitemid 128608316)
15. J.J. Gross, and O.P. John Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being J. Personal. Soc. Psychol. 85 2003 348 362 10.1037/0022-3514.85.2.348 (Pubitemid 37394968)
16. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 61
17. I. Hindmarch, and J.Z. Bhatti Psychopharmacological effects of sertraline in normal, healthy volunteers Eur. J. Clin. Pharmacol. 35 2 1988 221 223 10.1007/bf00609258
18. P. Kanske, J. Heissler, S. Schönfelder, and M. Wessa Neural correlates of emotion regulation deficits in remitted depression: the influence of regulation strategy, habitual regulation use, and emotional valence NeuroImage 61 3 2012 686 693 10.1016/j.neuroimage.2012.03.089
19. S.H. Kennedy, K.R. Evans, S. Kruger, H.S. Mayberg, J.H. Meyer, S. McCann, and F.J. Vaccarino Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression Am. J. Psychiatry 158 6 2001 899 905 10.1176/appi.ajp.158.6.899 (Pubitemid 32547619)
20. S.A. Moore, L.A. Zoellner, and N. Mollenholt Are expressive suppression and cognitive reappraisal associated with stress-related symptoms? Behav. Res. Ther. 46 9 2008 993 1000 10.1016/j.brat.2008.05.001
21. P.A. Newhouse, K.R. Krishnan, P.M. Doraiswamy, E.M. Richter, E.D. Batzar, and C.M. Clary A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients J. Clin. Psychiatry 61 8 2000 559 568 10.4088/JCP.v61n0804
22. J.B. Nezlek, and P. Kuppens Regulating positive and negative emotions in daily life J. Personal. 76 3 2008 561 580 10.1111/j.1467-6494.2008.00496.x
23. S. Pampallona, P. Bollini, G. Tibaldi, B. Kupelnick, and C. Munizza Combined pharmacotherapy and psychological treatment for depression: a systematic review Arch. Gen. Psychiatry 61 7 2004 714 719 10.1001/archpsyc.61.7. 714 (Pubitemid 38890806)
24. Y. Quidé, A.B. Witteveen, W. El-Hage, D.J. Veltman, and M. Olff Differences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: A systematic review Neuroscience & Biobehavioral Reviews 36 1 2012 626 644
25. Saveanu, R.; Etkin, A, Duchemin, A.-M.; Gyurak, A.; Debattisa, C.; Schatzberg, A.F.; Sood, S.; Day, C.; Wisniewski, S.R.; Palmer, D.M.; Rekshan, W.R.; Galatzer-Levy, I.; Gordon, E.; Rush, A.J.; Williams, L.M.; 2014. The international study to predict optimized treatment for depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment (in preparation).
26. P.A. Shapiro, F. Lespérance, N. Frasure-Smith, C.M. O′Connor, B. Baker, J.W. Jiang, and A.H. Glassman An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial) Am. Heart J. 137 6 1999 1100 1106 10.1016/s0002-8703(99)70369-8 (Pubitemid 30040735)
27. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller, and G.C. Dunbar The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J. Clin. Psychiatry 59 Suppl. 20 1998 22 33 (Pubitemid 29001829)
28. Y.I. Sheline, D.M. Barch, J.M. Donnelly, J.M. Ollinger, A.Z. Snyder, and M.A. Mintun Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study Biol. Psychiatry 50 9 2001 651 658 10.1016/s0006-3223(01)01263-x (Pubitemid 33043767)
29. G.J. Siegle, C.S. Carter, and M.E. Thase Use of fMRI to predict recovery from unipolar depression with cognitive behavior therapy Am. J. Psychiatry 163 4 2006 735 738 10.1176/appi.ajp.163.4.735 (Pubitemid 44464587)
30. M.E. Thase Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression: the venlafaxine XR 209 study group J. Clin. Psychiatry 58 9 1997 393 398 10.4088/JCP.v58n0904 (Pubitemid 27438691)
31. T.D. Wager, M.L. Davidson, B.L. Hughes, M.A. Lindquist, and K.N. Ochsner Prefrontal-subcortical pathways mediating successful emotion regulation Neuron 59 6 2008 1037 1050 10.1016/j.neuron.2008.09.006
32. L.M. Williams, A.J. Rush, S.H. Koslow, S.R. Wisniewski, N.J. Cooper, C.B. Nemeroff, and E. Gordon International study to predict optimized treatment for depression (iSPOT-D), a randomized clinical trial: rationale and protocol. [Article] Trials 12 1 2011 4 20 10.1186/1745-6215-12-4
33. C. Windischberger, R. Lanzenberger, A. Holik, C. Spindelegger, P. Stein, U. Moser, and S. Kasper Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study NeuroImage 49 2 2010 1161 1170 10.1016/j.neuroimage.2009.10.013
34. World Health Organisation, 2001. Atlas Mental Health Resources in the World, Geneva: WHO.
35. M. Zhong, X. Wang, J. Xiao, J. Yi, X. Zhu, J. Liao, and S. Yao Amygdala hyperactivation and prefrontal hypoactivation in subjects with cognitive vulnerability to depression Biol. Psychol. 88 2-3 2011 233 242 10.1016/j.biopsycho.2011.08.007